MENU
MRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mersana Therapeutics (MRSN) Ownership - Who owns Mersana Therapeutics?
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.39M
P/E Ratio
N/A
Total Cash
134.62M
Projected Growth
N/A
Total Debt
28.6M
Revenue
40.5M
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash/Share
1.08
Total Debt/Equity
N/A
Revenue/Share
0.33 USD as % of share price
Fundamentals
MRSN
Capitalization
37.4M
P/E Ratio
N/A
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash
135M
Total Cash/Share
1.08
Total Debt
28.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.33%
Revenue
40.5M
ROE
N/A
Book Value
-9.51M
P/B Ratio
61.73
Cash Flow
N/A
Earnings
-0.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
2.19
Current Revenue Per Employee
160401.95
Dividends Per Share - Security
N/A
EBITDA
-63.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.33
Shares Held By Institutions
176M
Shares Outstanding - Current
125M
Total Liabilities
154M
Total Volume MTD
N/A
Value
-1
Gain YTD
-79.538
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
840 Memorial Drive
Phone
+1 617 498-0020
Employees
123
Web
https://www.mersana.com